Mapping of long interspersed element-1 (L1) insertions by TIPseq provides information about sub chromosomal genetic variation in human embryos
Journal of Assisted Reproduction and Genetics · 2024
DOI: 10.1007/s10815-024-03176-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Assisted Reproduction and Genetics, 2024. Verfasst von Fabiana B Kohlrausch und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biologia Geral, Instituto de Biologia, Universidade Federal Fluminense, Niterói, RJ, 24210-201, Brazil. fabianabk@id.uff.br. Hauptthemen laut MEDLINE: Blastocyst, Long Interspersed Nucleotide Elements. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE: Retrotransposons play important roles during early development when they are transiently de-repressed during epigenetic reprogramming. Long interspersed element-1 (L1), the only autonomous retrotransposon in humans, comprises 17% of the human genome. We applied the Single Cell Transposon Insertion Profiling by Sequencing (scTIPseq) to characterize and map L1 insertions in human embryos. METHODS: Sixteen cryopreserved, genetically tested, human blastocysts, were accessed from consenting couples undergoing IVF at NYU Langone Fertility Center. Additionally, four trios (father, mother, and embryos) were also evaluated. scTIPseq was applied to map L1 insertions in all samples, using L1 locations reported in the 1000 Genomes as controls. RESULTS: Twenty-nine unknown and unique insertions were observed in the sixteen embryos. Most were intergenic; no insertions were located in exons or immediately upstream of genes. The location or number of unknown insertions did not differ between euploid and aneuploid embryos, suggesting they are not merely markers of aneuploidy. Rather, scTIPseq provides novel information about sub-chromosomal structural variation in human embryos. Trio analyses showed a parental origin of all L1 insertions in embryos. CONCLUSION: Several studies have measured L1 expression at different stages of development in mice, but this study for the first time reports unknown insertions in human embryos that were inherited from one parent, confirming no de novo L1 insertions occurred in parental germline or during embryogenesis. Since one-third of euploid embryo transfers fail, future studies would be useful for understanding whether these sub-chromosomal genetic variants or de novo L1 insertions affect embryo developmental potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Biologia Geral, Instituto de Biologia, Universidade Federal Fluminense, Niterói, RJ, 24210-201, Brazil. fabianabk@id.uff.br.
- Department of Obstetrics and Gynecology, New York University, New York, NY, 10016, USA. fabianabk@id.uff.br.
- Department of Obstetrics and Gynecology, New York University, New York, NY, 10016, USA.
- Institute for Systems Genetics, New York University, New York, NY, 10016, USA.
Zitieren
APA
Kohlrausch, F. B., Wang, F., McKerrow, W., Grivainis, M., Fenyo, D., & Keefe, D. L. (2024). Mapping of long interspersed element-1 (L1) insertions by TIPseq provides information about sub chromosomal genetic variation in human embryos. Journal of Assisted Reproduction and Genetics. https://doi.org/10.1007/s10815-024-03176-9
Vancouver
Kohlrausch FB, Wang F, McKerrow W, Grivainis M, Fenyo D, Keefe DL. Mapping of long interspersed element-1 (L1) insertions by TIPseq provides information about sub chromosomal genetic variation in human embryos. Journal of Assisted Reproduction and Genetics. 2024. doi:10.1007/s10815-024-03176-9
BibTeX
@article{Kohlrausch2024,
author = {Kohlrausch, Fabiana B and Wang, Fang and McKerrow, Wilson and Grivainis, Mark and Fenyo, David and Keefe, David L},
title = {Mapping of long interspersed element-1 (L1) insertions by TIPseq provides information about sub chromosomal genetic variation in human embryos},
journal = {Journal of Assisted Reproduction and Genetics},
year = {2024},
doi = {10.1007/s10815-024-03176-9}
}
EUVIMED